Neuroinflammation in glaucoma: a myriad of cellular pathways and players
Mammalian Genome · 2026
DOI: 10.1007/s00335-026-10253-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mammalian Genome, 2026. Verfasst von Michael MacLean und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory, Bar Harbor, ME, 04609, USA. Hauptthemen laut MEDLINE: Glaucoma, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 291 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Glaucoma Research Foundation, Bright Focus Foundation.
Abstract (Originalsprache)
Glaucoma is a complex neurodegenerative disease with multiple subtypes, yet all are characterized by the progressive dysfunction and loss of retinal ganglion cells (RGCs), which ultimately results in vision impairment and blindness. Elevated intraocular pressure (IOP) is a major risk factor for glaucoma; however, it is neither necessary nor sufficient for glaucomatous neurodegeneration, as patients can exhibit high IOP without developing glaucoma and patients can develop glaucoma with normal IOP. Yet FDA-approved treatment options are largely limited to approaches to minimize risk and reduce IOP. Thus, there is a critical need to target other aspects of glaucoma pathophysiology. Neuroinflammation is broadly defined here as immune-relevant responses, often involving microglia and astrocytes, within the central nervous system which may include peripheral immune cell infiltration. Burgeoning evidence has implicated glia in the development and progression of glaucoma in human tissues and mouse models. Most mouse models of glaucoma to date have shown that microglia and astrocytes are reactive in early stages of glaucomatous neurodegeneration prior to overt RGC loss. However, there is growing evidence that human and mouse glia adopt distinct phenotypes in response to neurodegeneration. Thus, there is critical need to expand our studies to include the new generations of human cell culture models. In this review, we discuss: 1) the evidence of neuroinflammatory processes in human glaucoma; 2) models of glaucoma relevant neuroinflammation; and the evidence specifically for 3) innate immune cell-driven and 4) macroglia-driven processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Jackson Laboratory, Bar Harbor, ME, 04609, USA.
- Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, USA.
- Neuroscience Graduate Program, University of Rochester Medical Center, Rochester, NY, USA.
- The Center for Visual Sciences, University of Rochester, Rochester, NY, USA.
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Förderung
- NEI NIH HHS
- Glaucoma Research Foundation
- Bright Focus Foundation
- National Eye Institute
- Diana Davis Spencer Foundation
Zitieren
APA
MacLean, M., Lydon, S. D., Gomes, C., Pizzi, E. M., Diemler, C. A., Yablonski, S. E. R., Howell, G. R., Meyer, J. S., & Libby, R. T. (2026). Neuroinflammation in glaucoma: a myriad of cellular pathways and players. Mammalian Genome. https://doi.org/10.1007/s00335-026-10253-0
Vancouver
MacLean M, Lydon SD, Gomes C, Pizzi EM, Diemler CA, Yablonski SER, et al. Neuroinflammation in glaucoma: a myriad of cellular pathways and players. Mammalian Genome. 2026. doi:10.1007/s00335-026-10253-0
BibTeX
@article{MacLean2026,
author = {MacLean, Michael and Lydon, Sean D and Gomes, Cátia and Pizzi, Elizabeth M and Diemler, Cory A and Yablonski, Sarah E R and Howell, Gareth R and Meyer, Jason S and Libby, Richard T},
title = {Neuroinflammation in glaucoma: a myriad of cellular pathways and players},
journal = {Mammalian Genome},
year = {2026},
doi = {10.1007/s00335-026-10253-0}
}
EUVIMED